Related Research Articles
Cardiomyopathy is a group of primary diseases of the heart muscle. Early on there may be few or no symptoms. As the disease worsens, shortness of breath, feeling tired, and swelling of the legs may occur, due to the onset of heart failure. An irregular heart beat and fainting may occur. Those affected are at an increased risk of sudden cardiac death.
Blood pressure (BP) is the pressure of circulating blood against the walls of blood vessels. Most of this pressure results from the heart pumping blood through the circulatory system. When used without qualification, the term "blood pressure" refers to the pressure in a brachial artery, where it is most commonly measured. Blood pressure is usually expressed in terms of the systolic pressure over diastolic pressure in the cardiac cycle. It is measured in millimeters of mercury (mmHg) above the surrounding atmospheric pressure, or in kilopascals (kPa). The difference between the systolic and diastolic pressures is known as pulse pressure, while the average pressure during a cardiac cycle is known as mean arterial pressure.
Pulse pressure is the difference between systolic and diastolic blood pressure. It is measured in millimeters of mercury (mmHg). It represents the force that the heart generates each time it contracts. Healthy pulse pressure is around 40 mmHg. A pulse pressure that is consistently 60 mmHg or greater is likely to be associated with disease, and a pulse pressure of 50 mmHg or more increases the risk of cardiovascular disease. Pulse pressure is considered low if it is less than 25% of the systolic. A very low pulse pressure can be a symptom of disorders such as congestive heart failure.
Restrictive cardiomyopathy (RCM) is a form of cardiomyopathy in which the walls of the heart are rigid. Thus the heart is restricted from stretching and filling with blood properly. It is the least common of the three original subtypes of cardiomyopathy: hypertrophic, dilated, and restrictive.
Paul M. Ridker is a cardiovascular epidemiologist and biomedical researcher. He is currently the Eugene Braunwald Professor of Medicine at Harvard University and Brigham and Women's Hospital, where he directs the Center for Cardiovascular Disease Prevention. Ridker also holds an appointment as Professor in the Department of Epidemiology at the Harvard T.H. Chan School of Public Health.
Amyloid cardiomyopathy is a condition resulting in the death of part of the myocardium. It is associated with the systemic production and release of many amyloidogenic proteins, especially immunoglobulin light chain or transthyretin (TTR). It can be characterized by the extracellular deposition of amyloids, foldable proteins that stick together to build fibrils in the heart.
Eric Newell Olson is an American molecular biologist. He is professor and chair of the Department of Molecular Biology at the University of Texas Southwestern Medical Center in Dallas, where he also holds the Robert A. Welch Distinguished Chair in Science, the Annie and Willie Nelson Professorship in Stem Cell Research, and the Pogue Distinguished Chair in Research on Cardiac Birth Defects.
Pulmonary vein stenosis is a rare cardiovascular disorder. It is recognized as being the stenosis of one or more of the four pulmonary veins that return blood from the lungs to the left atrium of the heart. In congenital cases, it is associated with poor prognosis and high mortality rate. In some people, pulmonary vein stenosis occurs after pulmonary vein ablation for the treatment of atrial fibrillation. Some recent research has indicated that it may be genetically linked in congenital cases.
James S. Forrester III is an American cardiologist. Born in Philadelphia, Pennsylvania, he received his medical training at the University of Pennsylvania, UCLA, and Harvard University. During the 1970s through 1990s, his research led to three major advancements in the practice of cardiology. Later in his career, he would return to UCLA, this time as a professor, while simultaneously being the Chief of the Division of Cardiology at Cedars-Sinai Medical Center. Forrester has published hundreds of papers and manuscripts dealing with the subject of cardiology, and is the recipient of numerous awards, including being the second person to ever receive the Lifetime Achievement Award of the American College of Cardiology in 2009.
Edmund Hiram Sonnenblick was an American medical researcher and cardiologist. His studies of the function of cardiac muscle cells during the 1960s shaped the basis of both cardiovascular physiology and the modern treatment of cardiovascular disease, making possible the development of ACE inhibitors. In 1962, he was credited as the first person to image the heart muscle under scientifically-controlled conditions using the electron microscope. Though Sonnenblick's ideas about the relationship between the structure and function of the human heart today constitute medical-scientific commonsense, they were utterly novel at the time.
David Alfred Eisner, FRCP (Hon), FMedSci, is British Heart Foundation Professor of Cardiac Physiology at the University of Manchester and editor-in-chief of The Journal of General Physiology (JGP).
Garret Adare FitzGerald is an Irish physician. He is professor of translational medicine and therapeutics and chair of the department of pharmacology at the Perelman School of Medicine of the University of Pennsylvania. He researches aspects of cardiology, pharmacology, translational medicine, and chronobiology.
Douglas L. Mann is an American physician. He is currently the Ada L. Steininger Professor of Cardiology and professor of medicine, cell biology and physiology at Washington University School of Medicine in St. Louis.
Kiran Musunuru is an American cardiologist who is a Professor of Medicine at the University of Pennsylvania Perelman School of Medicine. He researches the genetics and genomics of cardiovascular and metabolic diseases. Musunuru is a leading expert in the field of gene-editing.
Michelle Asha Albert is an American physician who is the Walter A. Haas Lucie-Stern Endowed Chair in Cardiology and professor of medicine at the University of California, San Francisco. Albert is director of the UCSF Center for the Study of Adversity and Cardiovascular Disease. She is president of the American Heart Association. She served as the president of the Association of Black Cardiologists in 2020–2022 and as president of the Association of University Cardiologists (2021–2022). Albert is an elected member of the National Academy of Medicine, the American Society of Clinical Investigators and the Association of American Physicians.
Martha Gulati is the past Chief of Cardiology at the University of Arizona, Phoenix. She previously held the Sarah Ross Soter Chair in Women’s Cardiovascular Health at the Ohio State University. Gulati is the Chair of the National Chest Pain Guidelines. She is the author of the popular science book Saving Women’s Heart and Editor-in-Chief of materials for the American College of Cardiology programme CardioSmart.
Elizabeth M. McNally is an American human geneticist and cardiologist. She is the Elizabeth J. Ward Chair and director of the Center for Genetic Medicine at Northwestern University's Feinberg School of Medicine.
Jane Wimpfheimer Newburger is an American pediatrician who is Commonwealth Professor of Pediatrics at Harvard Medical School and Associate Cardiologist-in-Chief at the Boston Children's Hospital. Her research has considered the fundamental mechanisms that underpin Kawasaki disease and the outcomes of children suffering from congenital heart defects. She was elected Fellow of the National Academy of Medicine in 2021.
Jane Mitchell is a professor of pharmacology in clinical care medicine at Imperial College London. Her research focusses on the regulation of cardiovascular health and disease, with a particular interest in endothelial cells, prostacyclin, and nitric oxide.
Filip Swirski is a Polish-Canadian-American scientist and educator serving as the Arthur and Janet C. Ross Professor of Medicine, Cardiology and Professor of Radiology at the Icahn School of Medicine at Mount Sinai and is the Director of the Cardiovascular Research Institute. He is also a member of the Biomedical Engineering and Imaging Institute (BMEII), the Marc and Jennifer Lipschultz Precision Immunology Institute (PrIISM), and The Friedman Brain Institutes (FBI) at Mount Sinai. His research partly focuses on innate and inflammatory mechanisms in cardiovascular disease. He is known for his work in cardioimmunology and notably for linking atherosclerosis with blood monocytosis.
References
- 1 2 Landau, Elizabeth (21 June 2013). "Doctor is pain medicine 'visionary'". CNN. Retrieved 20 September 2018.
- ↑ Genest, Jacques; Hébert, Terence E.; Martin, James (13 October 2016). "The Louis and Artur Lucian Award in Cardiovascular Diseases at McGill University". Circulation Research. 119 (9). Ovid Technologies (Wolters Kluwer Health): 975–977. doi: 10.1161/circresaha.116.309972 . ISSN 0009-7330.
- ↑ "Fifty Years of Philanthropy: The Louis and Artur Lucian Award in Cardiovascular Diseases at McGill University". Canadian Journal of Cardiology. 31 (7). Elsevier BV: 949–954. 2015. doi: 10.1016/j.cjca.2015.05.011 . ISSN 0828-282X.
- ↑ Ince, Susan (7 December 2017). "2017 Lucian Award". Circulation Research. 121 (12). Ovid Technologies (Wolters Kluwer Health): 1312–1315. doi: 10.1161/circresaha.117.312359 . ISSN 0009-7330.
 | This award-related article is a stub. You can help Wikipedia by expanding it. |
 | This cardiovascular system article is a stub. You can help Wikipedia by expanding it. |